Efficacy of the based on the ASD-2 fraction drug composition for correction of dyspeptic manifestations in calves

The scientific article is devoted to evaluation of the original author's composition effectiveness for prevention and treatment of dyspepsia in newborn calves from BLV-infected cows. It is shown that use of the composition for prophylactic purposes reduces possibility of dyspepsia development in 20.82 % calves, and for therapeutic purposes reduces the treatment duration of dyspeptic manifestations in 28.35 % of newborn calves up to 3 days and increases the safety of livestock up to 100%. The obtained data are supported by the results of morphological and biochemical analyses of calves' blood, microbiological studies of the intestinal contents, indicating a rapid recovery of the animal homeostasis with opportune use of the composition for preventive or therapeutic purposes. It was found that use of the author's development allows us to keep the weight gain in calves from immunocompromised mothers at the level of intact animals.